Deacetylation of ATG16L1 is required for LC3-associated lysosomal microautophagy
- Autophagy. 2025 Aug 28:1-15. doi: 10.1080/15548627.2025.2551669.
- 1. Center for Metabolism Research, International Institutes of Medicine, International School of Medicine and the Fourth Affiliated Hospital of Zhejiang University, Yiwu, China.
- 2. Department of Biochemistry, and Department of Thoracic Surgery of Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China.
- 3. Faculty of Health Sciences, Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macau, China.
- 4. Department of Ultrasound Medicine and State Key laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Microautophagy is a selective cellular process in which endolysosomes directly engulf cytoplasmic cargo through membrane invagination. The regulatory mechanisms governing microautophagy remain poorly understood. Here, we identified the deacetylation of ATG16L1 as a critical regulator of LC3-associated lysosomal microautophagy. We demonstrate that ATG16L1 acetylation is dynamically controlled by the acetyltransferase KAT2B and the deacetylase HDAC3. Under lysosomal osmotic stress or glucose deprivation, HDAC3-mediated deacetylation of ATG16L1 within its WD40 domain promotes its interaction with V-ATPase, facilitating ATG16L1 recruitment to lysosomal membranes. While dispensable for macroautophagy, this post-translational modification is essential for LC3 lipidation on lysosomes and enables lysosomal recovery, including the restoration of lysosomal size and degradative capacity following stress. Our results reveal a key role for ATG16L1 deacetylation in driving LC3-associated microautophagy to maintain lysosomal homeostasis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
Research Areas: Cancer
-
-
target: LRRK2Research Areas: Neurological Disease
-